The DEEP project has received research funding from the European Union under the 7th Framework Programme

Universitätsklinikum Erlangen (UKER)

The University of Erlangen-Nuremberg is one of Germany’s largest universities. “Advance through Networks”, the mission statement it has adopted, has been inspired by the lively dialogue between subjects and faculties that typifies the University and that has given rise to an almost unique range of interdisciplinary courses. The main focus in research and teaching is to be found at the interface between Natural Sciences, Engineering and Medicine in close cooperation with the classical university disciplines Law, Theology and the Humanities. Economics, Social and Educational Sciences complete the range of subjects offered.

Main tasks in the project

Within the project, the University Hospital Erlangen will predominantly be involved in pharmacovigilance WP5 such as protocol development, patient recruitment and data analysis. UKER will be also involved in the project for the development of the WP6 task 6.5 (market evaluation) and 6.6 (Pharmacoeconomic evaluation).

University Hospital Erlangen
Department of Paediatrics and Adolescent Medicine
Paediatric Clinical Study Centre
Loschgestr. 15
91054 Erlangen, Germany